OssDsign Appoints Mark Waugh as CEO, Focuses on US Growth

OssDsign AB, an Uppsala-based medical technology company, has appointed Mark Waugh as its new Chief Executive Officer, effective January 1, 2026. Mr. Waugh will be based in the United States, operating from the company’s Maryland office and his home office in Indiana. This strategic placement underscores OssDsign's commitment to strengthening its presence in the critical American market. He succeeds Morten Henneveld, who is stepping down after five years as CEO. Mr. Waugh brings over two decades of leadership experience in the orthopedics and spinal surgery industries. His extensive career includes senior leadership positions at Smith & Nephew plc and Medtronic Sofamor Danek Inc. Most recently, he served as Senior Vice President of Commercial Operations at Medacta USA. In his new role, Mr. Waugh will be responsible for accelerating growth in the U.S. and other key markets, including Europe. According to Simon Cartmell, Chairman of the Board at OssDsign, this appointment signifies the company's "next phase of growth and development." Mr. Cartmell emphasized Mr. Waugh’s deep experience in orthopedics and spinal surgery, as well as his "documented ability to drive sales growth," as pivotal factors in the selection process.